Alkermes plc
NASDAQ: ALKS
$28.97
+$0.60 (+2.1%)
Closing Price on October 4, 2024
ALKS Articles
Active traders and day traders have many stocks to choose from this Wednesday morning. We are tracking news and moves in shares of Some of the most active stocks or largest moves seen in shares...
Published:
Last Updated:
These are some of this Thursday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Agrium Inc. (NYSE: AGU) Removed from TD’s Action Buy List but target raised...
Published:
Last Updated:
Active traders and day traders have many stocks to choose from this Wednesday morning. We are tracking news and moves in shares of Some of the most active stocks or largest moves seen in shares of...
Published:
Last Updated:
The world of biotech and biohealth is seeing a flurry of news today. This is bringing on many winners and losers in the sector. We are tracking the news and the moves in Alexza Pharmaceuticals...
Published:
Last Updated:
Earnings season is just getting underway and the Dow Jones Industrial Average hit 11,000 on Friday. There are many stocks to watch outside of earnings this week. The cast of characters in The...
Published:
Last Updated:
These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research notes: Alkermes, Inc. (NASDAQ: ALKS) Started as Buy at UBS. Altria Group Inc.(NYSE:...
Published:
Last Updated:
There are many key movers in today’s BioHealth Business Daily. We have included background data, news, reactions, and added in color where applicable. BioHealth stocks to watch today are Amgen...
Published:
Last Updated:
There are many big movers today in the day trader and active trader alerts. Stocks on the move are ARM Holdings plc (NASDAQ: ARMH), A-Power Energy Generation Systems, Ltd. (NASDAQ: APWR), Alkermes,...
Published:
Last Updated:
This week we have several issues to watch. Earnings season is mostly done but there are still many on deck in this week’s unusual suspects. Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN), Eli...
Published:
Last Updated:
This week’s list of UNUSUAL SUSPECTS for stocks to watch is actually much different from what we have seen in other reports. Earnings season is finally over, so we only have two earnings we gave...
Published:
Last Updated:
It is fairly light out in there in realm of analyst downgrades this morning. These are this Thursday’s top analyst downgrades or cautious calls from Wall Street this morning: Alkermes (ALKS) Cut...
Published:
These are some of this morning’s top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume...
Published:
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq:...
Published:
Amylin Pharmaceuticals, Inc., (NASDAQ: AMLN) has been a battered biotech lately. But shares have just now gotten back above the single-digit threshold and are up more than 80% from recent lows. ...
Published:
Alkermes (NASDAQ: ALKS) and Johnson & Johnson Pharmaceutical Research and Developed today submitted paperwork seeking approval of their partnership drug, RISPERDAL CONSTA, to be allowed for...
Published: